ID
45160
Descrição
Principal Investigator: Mark A. Rubin, MD, Weill Cornell Medical College, New York, NY, USA MeSH: Prostatic Neoplasms https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000311 We have developed FusionSeq to identify fusion transcripts from paired-end RNA-sequencing. FusionSeq includes filters to remove spurious candidate fusions with artifacts such as misalignments or random pairing of transcript fragments and it ranks candidates according to several statistics. It also has a module to identify exact sequences at breakpoint junctions. FusionSeq detected known and novel fusions in a specially sequenced calibration data set, including 8 cancers with and without known rearrangements.
Link
Palavras-chave
Versões (2)
- 28/08/2022 28/08/2022 - Simon Heim
- 12/10/2022 12/10/2022 - Adrian Schulz
Titular dos direitos
Mark A. Rubin, MD, Weill Cornell Medical College, New York, NY, USA
Transferido a
12 de outubro de 2022
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
dbGaP phs000311 FusionSeq: Finding Fusions with Paired-End RNA-Seq
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, subject source, consent group, and affection status of participants with prostate cancer.
- Sample ID and sample source of participants with prostate cancer.
- Subject age, height, and family history of participants with prostate cancer.
- Sample ID, sample and tumor characteristics including tumor stage, grade, location, and sample type of participants with prostate cancer.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, subject source, consent group, and affection status of participants with prostate cancer.
- Sample ID and sample source of participants with prostate cancer.
- Subject age, height, and family history of participants with prostate cancer.
- Sample ID, sample and tumor characteristics including tumor stage, grade, location, and sample type of participants with prostate cancer.
C0586597 (UMLS CUI [1,2])
C2922133 (UMLS CUI [1,3])
C0027651 (UMLS CUI [1,4])
C1268672 (UMLS CUI [1,5])
C1512693 (UMLS CUI [2,1])
C0012854 (UMLS CUI [2,2])
C0370003 (UMLS CUI [2,3])
C0586597 (UMLS CUI [2,4])
C0178913 (UMLS CUI [2,5])
C0332152 (UMLS CUI [2,6])
C0033573 (UMLS CUI [2,7])